Home > Boards > Free Zone > User's Groups > 123Tom's TA study group.

Just curious. Did this come up in a

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Citrati Member Profile
Followed By 311
Posts 15,026
Boards Moderated 0
Alias Born 01/02/10
160x600 placeholder
Newmont Expects Fiscal Year Results to Include Continued Effects From Covid-19, Other Challenges -- Commodity Comment
By Dave Sebastian Newmont Corp. said it expects its full-year results to include continued effects from Covid-19 and other challenges.
U.S. Economy Grew by 2.0% in 3Q
Illinois Tool Works Cuts 2021 Earnings Guidance on Auto-Production Levels
Spero Therapeutics Submits NDA for Treatment of Urinary Tract Infections
Illinois Tool Works 3Q Profit, Revenue Rise
Mastercard 3Q Revenue Grows on Higher Dollar Volume
German Inflation Rose by More Than Expected in October
ECB Leaves Monetary Stimulus Unchanged Amid Surging Inflation
Intercontinental Exchange 3Q Revenue Grows, Beats Analyst Expectations
Volkswagen CEO Says Productivity Needs to Improve, Warns of Job Cuts
HCW Biologics Gets FDA Clearance to Proceed With Cancer-Treatment Trial
Newmont 3Q Profit, Sales Fall on Lower Gold Production
Ambev Posted 3Q Net Profit of BRL3.6 Billion as Pandemic Recovery Continued
Linde 3Q Profit Rose on High Demand, Raises 2021 EPS Views
FTSE 100 Down, Sterling Gains Seen as Limited Amid Economic Headwinds
Airbus Raises 2021 Cash Flow, Earnings Targets; Adjusts Production Ramp-Up Plans -- 2nd Update
Deepverge Equipment Selected for UK Covid-19 Infrastructure Trial
Fluence Energy Shares Set for Trading Debut After IPO Priced Above Views
North American Morning Briefing: Stock Futures Inch Up Ahead of GDP Data
Standard Chartered Sets Targets to Cut Financed Emissions From Carbon-Intensive Sectors
SK Innovation Teams Up With Solid Power to Make Solid-State EV Batteries
Belgian Economy Gains Pre-Pandemic Levels
Philips Sets Ambition to Decarbonize Supply Chain
Checkit Signs Contact With BP to Rollout Platform to More Forecourts
Shell Was Hurt by Lower Production, Weaker Trading Profits in 3Q -- Commodity Comment
Citrati   Sunday, 06/27/21 04:22:25 PM
Re: Phoenix300 post# 10435
Post # of 10577 
Just curious. Did this come up in a scan? Maybe following since its IPO? Are you just looking for approval or more interested in partnership/buyout potential?

Do you consider this info reliable?

ITRM> Institutional ownership. ~70%. You don't see this type of ownership level very often with small cap biopharma companies
**************************Received a CRL from FDA in July last. Something about revising data submitted. PR from ITRM said they didn't have the financing to complete the study. Sarissa Cap and R A Capital invested in Sept/ Sarissa to the tune of 40% ownership with rights to buy more. (activist investment). ITRM recently applied and was given NDA approval for their drug. PDUFA date for approval of drug is early July 21. The company is set up for a buyout. They only have 4 employees/ no sales staff/ Denner from Sarissa is a turnaround-buyout specialist/ ITRM recently partnered with an outside company to market and sell drug (IMO just to increase buyout price/ and just did a shelf BOUGHT offering, possibly so Sarissa can exercise it's right to buy more (just my theory)/ and by increasing number of shares it also increases buyout price. If they went in to a buyout negotiation with only 4 employees and no sales infrastructure they would get raped on the price, hence the recent moves. Fascinating!

Alex & Sarissa are known from above link and many others of turning Bio companies in to large profitable buyouts. Sarissa currently owns 33% of ITRM with a special clause for obtaining 60% total ownership of the outstanding shares.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences